Annual oral glucose tolerance testing (OGTT) is the recommended screening modality for cystic fibrosis‐related diabetes (CFRD) in patients with cystic fibrosis (CF). This study aimed to determine if there were… Click to show full abstract
Annual oral glucose tolerance testing (OGTT) is the recommended screening modality for cystic fibrosis‐related diabetes (CFRD) in patients with cystic fibrosis (CF). This study aimed to determine if there were patterns of progression of worsening glucose homeostasis in pediatric CF patients and to explore any relationship to lung function.
               
Click one of the above tabs to view related content.